FUKOKU MUTUAL LIFE INSURANCE Co Sells 313 Shares of Danaher Co. (NYSE:DHR)

FUKOKU MUTUAL LIFE INSURANCE Co cut its position in shares of Danaher Co. (NYSE:DHR) by 10.0% in the 3rd quarter, HoldingsChannel reports. The institutional investor owned 2,813 shares of the conglomerate’s stock after selling 313 shares during the quarter. FUKOKU MUTUAL LIFE INSURANCE Co’s holdings in Danaher were worth $782,000 at the end of the most recent quarter.

Other institutional investors have also added to or reduced their stakes in the company. Sargent Investment Group LLC boosted its stake in Danaher by 12.3% in the third quarter. Sargent Investment Group LLC now owns 12,636 shares of the conglomerate’s stock worth $3,513,000 after buying an additional 1,384 shares in the last quarter. Tokio Marine Asset Management Co. Ltd. raised its holdings in shares of Danaher by 4.5% in the 3rd quarter. Tokio Marine Asset Management Co. Ltd. now owns 18,812 shares of the conglomerate’s stock valued at $5,230,000 after purchasing an additional 807 shares in the last quarter. KBC Group NV increased its stake in Danaher by 36.8% during the 3rd quarter. KBC Group NV now owns 282,386 shares of the conglomerate’s stock valued at $78,508,000 after purchasing an additional 76,017 shares in the last quarter. Kovack Advisors Inc. raised its position in shares of Danaher by 3.4% in the third quarter. Kovack Advisors Inc. now owns 1,243 shares of the conglomerate’s stock worth $346,000 after acquiring an additional 41 shares during the period. Finally, Oppenheimer & Co. Inc. boosted its stake in Danaher by 0.5% during the third quarter. Oppenheimer & Co. Inc. now owns 25,120 shares of the conglomerate’s stock worth $6,984,000 after buying an additional 116 shares during the last quarter. 79.05% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, SVP Georgeann Couchara sold 952 shares of Danaher stock in a transaction on Monday, August 26th. The stock was sold at an average price of $268.37, for a total transaction of $255,488.24. Following the transaction, the senior vice president now directly owns 4,212 shares in the company, valued at approximately $1,130,374.44. This trade represents a 18.44 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 11.10% of the stock is currently owned by insiders.

Analyst Ratings Changes

A number of brokerages have recently issued reports on DHR. Barclays dropped their price target on shares of Danaher from $285.00 to $275.00 and set an “equal weight” rating on the stock in a research note on Wednesday, October 23rd. The Goldman Sachs Group lifted their price objective on Danaher from $225.00 to $250.00 and gave the company a “neutral” rating in a research report on Wednesday, July 24th. KeyCorp boosted their price target on shares of Danaher from $290.00 to $310.00 and gave the company an “overweight” rating in a research report on Wednesday, October 23rd. Royal Bank of Canada decreased their price objective on Danaher from $333.00 to $311.00 and set an “outperform” rating for the company in a report on Wednesday, October 23rd. Finally, Wolfe Research upgraded shares of Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 price objective for the company in a research report on Thursday, October 31st. Five analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $287.16.

Danaher Price Performance

Shares of DHR opened at $239.45 on Friday. Danaher Co. has a 1 year low of $204.15 and a 1 year high of $281.70. The company has a market capitalization of $172.95 billion, a price-to-earnings ratio of 45.70, a price-to-earnings-growth ratio of 4.44 and a beta of 0.85. The business has a 50-day moving average of $263.42 and a 200-day moving average of $260.64. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.37 and a quick ratio of 1.01.

Danaher (NYSE:DHR) last released its quarterly earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 EPS for the quarter, beating the consensus estimate of $1.57 by $0.14. The firm had revenue of $5.80 billion during the quarter, compared to analyst estimates of $5.59 billion. Danaher had a net margin of 16.39% and a return on equity of 10.62%. The business’s revenue for the quarter was up 3.1% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $2.02 EPS. As a group, equities research analysts anticipate that Danaher Co. will post 7.51 earnings per share for the current year.

Danaher Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, October 25th. Stockholders of record on Friday, September 27th were issued a $0.27 dividend. The ex-dividend date was Friday, September 27th. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.45%. Danaher’s payout ratio is 20.61%.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.